当前位置:首页 - 行情中心 - 奥泰生物(688606) - 财务分析

奥泰生物

(688606)

  

流通市值:54.00亿  总市值:54.00亿
流通股本:7928.09万   总股本:7928.09万

奥泰生物(688606)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.98亿元,每股收益2.49元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益388393.39万元,未分配利润192241.09万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产416466.45万元,负债28073.06万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入618,025,472.14396,503,367.26199,920,896.28754,696,888.86
营业总成本425,103,891.99272,928,388.15144,138,319.97592,083,574.56
营业利润226,782,476.67142,049,648.0247,328,962.37211,581,308.18
利润总额223,317,711.2139,148,631.9447,157,267.14197,438,750.23
净利润197,545,161.13123,534,579.7444,644,329.67180,280,608.17
其他综合收益-1,478,128.56648,531.96151,351.082,367,625.72
综合收益总额196,067,032.57124,183,111.744,795,680.75182,648,233.89
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计3,022,645,424.213,052,053,838.213,065,860,380.343,161,447,852.41
非流动资产合计1,142,019,061.141,127,283,564.591,074,979,926.59954,609,920.46
资产总计4,164,664,485.354,179,337,402.84,140,840,306.934,116,057,772.87
流动负债合计274,294,586.14362,226,479.15285,926,688.19274,163,012.47
非流动负债合计6,436,013.677,979,902.6212,126,917.2710,336,693.2
负债合计280,730,599.81370,206,381.77298,053,605.46284,499,705.67
归属于母公司股东权益合计3,879,604,483.723,805,154,944.733,838,615,607.633,827,249,132.73
股东权益合计3,883,933,885.543,809,131,021.033,842,786,701.473,831,558,067.2
负债和股东权益合计4,164,664,485.354,179,337,402.84,140,840,306.934,116,057,772.87
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计637,594,172.93418,257,590.29203,888,757.66779,585,951.22
经营活动现金流出小计445,876,279.67315,505,429.34164,807,295.14754,822,255.77
经营活动产生的现金流量净额191,717,893.26102,752,160.9539,081,462.5224,763,695.45
投资活动现金流入小计2,012,309,429.51,408,255,432.76866,426,537.51,798,272,033.92
投资活动现金流出小计2,163,512,053.891,766,857,239.13942,677,905.631,938,940,093.31
投资活动产生的现金流量净额-151,202,624.39-358,601,806.37-76,251,368.13-140,668,059.39
筹资活动现金流入小计2,472,848.551,419.66-8,936,886.08
筹资活动现金流出小计158,081,236.1589,984,314.2439,515,312.05567,727,686.57
筹资活动产生的现金流量净额-155,608,387.6-89,982,894.58-39,515,312.05-558,790,800.49
汇率变动对现金及现金等价物的影响-5,435,286.162,028,379.3446,117.429,477,616.49
现金及现金等价物净增加额-120,528,404.89-343,804,160.66-76,639,100.24-665,217,547.94
期末现金及现金等价物余额1,196,096,820.99972,821,065.221,239,986,125.641,316,625,225.88
TOP↑